Imperative Care concludes subject enrolment in pulmonary embolism study

Combination of ultrasound waves and catheter technology improves treatment success The Department of Cardiology and Cardiological Intensive Care at the AMEOS Klinikum St. Clemens Oberhausen is the only one in the region to apply an innovative treatment for acute, life-threatening pulmonary embolism.The minimally invasive method is a combination of ultrasound and catheter technology, which, with targeted medication and ultrasound technology, prov…

Imperative Care concludes subject enrolment in pulmonary embolism study

Imperative Care has completed subject enrolment in the pivotal IDE trial, SYMPHONY-PE, to treat acute pulmonary embolism.The post Imperative Care concludes subject enrolment in pulmonary embolism study appeared first on Medical Device Network.

Imperative Care’s SYMPHONY-PE IDE Study Completes Enrollment - Endovascular Today

May 13, 2025—Imperative Care, Inc announced the completion of patient enrollment in its SYMPHONY-PE study, which was conducted at 19 interventional radiology, interventional cardiology, and vascular surgery centers across the United States. According to Imperative Care, the pivotal investigational device exemption (IDE) trial is evaluating the safety and efficacy of the company’s Symphony thrombectomy system for the treatment of acute pulmonary …

Imperative Care announces completion of enrollment in the SYMPHONY-PE study - Interventional News

Imperative Care today announced the completion of patient enrolment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and efficacy of the company’s Symphony thrombectomy system for the treatment of acute pulmonary embolism (PE). Designed to expand Symphony’s current indication for use to include PE, the study was conducted at 19 leading interventional radiology, interventional cardiology and v…